A recent study evaluated, for the first time, the association of a microbiome treatment in a controlled setting to treat recurrent Clostridiodes difficile infection. Read this infographic to gain more insights on role of microbiome in disorders related to gut-brain axis! Do you think a microbiome therapeutic like SER-109 can successfully be used as a drug for treating recurrent Clostridiodes difficile infections?

Share your views by commenting below!